Emerging roles of EGFL family members in neoplastic diseases: Molecular mechanisms and targeted therapies
Authors:
- 3 March 2025
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 236, 116847
Abstract
No abstract availableKeywords
Funding Information
- Suzhou Municipal Health Commission
- Xuzhou Medical University
This publication has 148 references indexed in Scilit:
- Celsr2‐mediated morphological polarization and functional phenotype of reactive astrocytes in neural repairGlia, 2023
- Proteomics identifies EGF‐like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor‐positive gliomaCancer Communications, 2020
- Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) ‐ outcomes and mutation profile from venetoclax resistant MCL patientsAmerican Journal of Hematology, 2020
- Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinomaCancer Medicine, 2018
- Generation and characterization of Megf6 null and Cre knock‐in allelesGenesis, 2018
- Delta‐like 2 negatively regulates chondrogenic differentiationJournal of Cellular Physiology, 2017
- EGFL7 Is Expressed in Bone Microenvironment and Promotes Angiogenesis via ERK, STAT3, and Integrin Signaling CascadesJournal of Cellular Physiology, 2014
- Novel role for epidermal growth factor‐like domain 7 in metastasis of human hepatocellular carcinoma†Hepatology, 2009
- Identification of differentially methylated CpG islands in prostate cancerInternational Journal of Cancer, 2004
- Egfl7, a novel epidermal growth factor‐domain gene expressed in endothelial cellsDevelopmental Dynamics, 2004